Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

Sanofi says arbitration court rejects Boehringer's Zantac claims
Reuters
Wed, 06/21/23 - 10:53 am
Tags:
Sanofi, Boehringer Ingelheim, Zantac, legal
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
Benzinga
Tue, 06/20/23 - 09:46 pm
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, Synjardy, type 2 diabetes, pediatric, FDA
Late-stage pipeline for idiopathic pulmonary fibrosis is small but growing
Clinical Trials Arena
Mon, 06/19/23 - 11:39 am
Tags:
IPF, Roche, Esbriet, Pirespa, Boehringer Ingelheim, Ofev
Yuhan makes $325M cancer bet to challenge Boehringer, Takeda
Fierce Pharma
Wed, 05/31/23 - 06:59 pm
Tags:
Yuhan, cancer, Boehringer Ingelheim, Takeda, HER2 inhbitor, non-small cell lung cancer
Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial
BioSpace
Wed, 05/10/23 - 10:21 am
Tags:
Boehringer Ingelheim, Zealand Pharma, obesity, clinical trials, BI 456906
Boehringer Ingelheim to Mine Ginkgo’s Molecules in $406M Undruggable Targets Deal
BioSpace
Mon, 05/8/23 - 11:30 pm
Tags:
Boehringer Ingelheim, Ginko Bioworks, bioactive molecules
Boehringer Ingelheim to surf with Melbourne-based biotech in $181M neuropsychiatric therapy deal
Fierce Biotech
Fri, 05/5/23 - 11:53 am
Tags:
Boehringer Ingelheim, Kinoxis Therapeutics, neuropsychiatric
Boehringer Ingelheim breaks ground on €285M API plant in Germany
Fierce Pharma
Wed, 05/3/23 - 11:35 am
Tags:
Boehringer Ingelheim, drug manufacturing, Germany
Boehringer Ingelheim opens new biotechnology R&D center in Germany
Pharmaceutical Business Review
Tue, 04/25/23 - 10:41 am
Tags:
Boehringer Ingelheim, Germany, R&D
Playing catch-up, Boehringer taps RetinAI for AI boost to eye disease R&D
Fierce Biotech
Fri, 04/21/23 - 10:14 am
Tags:
Boehringer Ingelheim, RetinAI, artificial intelligence, geographic atrophy, R&D
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
Tags:
CVS Health, Signify Health, M&A, Ferring Pharmaceuticals, Pfizer, Bristol Myers Squibb, Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Jardiance, Ozempic, drug pricing, Eliquis, CMS
Mon, 04/3/23 - 03:26 pm
Tags:
CVS Health, Signify Health, M&A, Ferring Pharmaceuticals, Pfizer, Bristol Myers Squibb, Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Jardiance, Ozempic, drug pricing, Eliquis, CMS
Boehringer signals intent in obesity
EP Vantage
Thu, 03/30/23 - 10:05 am
Tags:
Boehringer Ingelheim, Zealand Pharma, obesity, clinical trials, BI 456906
Boehringer Ingelheim and Eli Lilly's Jardiance gets big lift from heart failure indications
Fierce Pharma
Wed, 03/29/23 - 04:01 pm
Tags:
Boehringer Ingelheim, Eli Lilly, Jardiance, heart failure
Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients
Marketscreener
Tue, 03/28/23 - 10:20 am
Tags:
Covant Therapeutics, drug discovery, R&D, Boehringer Ingelheim, cancer, ADAR1
Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report
Fierce Pharma
Tue, 02/28/23 - 10:39 pm
Tags:
Medicare, drug pricing, Merck, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, JNJ
Spotlight – Cystic fibrosis developers take a deep breath
EP Vantage
Mon, 02/27/23 - 10:02 am
Tags:
cystic fibrosis, MRNA, Vertex Pharmaceuticals, 4D Molecular Therapeutics, Arcturus Therapeutics, Arrowhead Pharmaceuticals, Boehringer Ingelheim, Eloxx Pharmaceuticals, Krystal Biotech, Moderna Therapeutics, Oxford BioMedica, ReCode Therapeutics, SpliSense, Sumitomo Pharmaceuticals, Tessera Therapeutics
New Report Reveals Pharmaceutical Industry Social Media Pioneers
LBB Online
Fri, 02/24/23 - 08:52 am
Tags:
Ogilvy Health, social media, Bristol Myers Squibb, Boehringer Ingelheim, Roche
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
Tags:
television ads, pharma marketing, DTC ads, AbbVie, Rinvoq, Dupixent, Sanofi, Regeneron, Skyrizi, Novo Nordisk, Ozempic, Jardiance, Eli Lilly, Boehringer Ingelheim, Rybelsus, Trulicity, Rexulti, Otsuka, Lundbeck, Tremfya, JNJ, Verzenio
Roche, Boehringer tap biosensor firms for patient studies
Pharmaphorum
Thu, 01/26/23 - 10:58 am
Tags:
Roche, Boehringer Ingelheim, patient monitoring, biosensors, clinical trials, Sysnav Healthcare, Strados Labs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.